Skip to main content
OpenTrials

Clinical trial condition

Central Nervous System Infections

Explore clinical trials studying Central Nervous System Infections. Study availability and eligibility vary by location and protocol.

746 public trials 77 recruiting studies
Refine in advanced search Browse all conditions

Central Nervous System Infections trial results

Completed

Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery

NCT02853929

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +37 more
Locations
  • GSK Investigational Site Carlton, Victoria, Australia
  • GSK Investigational Site Calgary, Alberta, Canada
  • GSK Investigational Site Halifax, Nova Scotia, Canada
  • GSK Investigational Site Montreal, Quebec, Canada
View all 29 locations
View Trial Details
Completed

Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age).

NCT00352963

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +28 more
Locations
  • GSK Investigational Site Alcorcón, Spain
  • GSK Investigational Site Almeira, Spain
  • GSK Investigational Site Badalona, Spain
  • GSK Investigational Site Barcelona, Spain
View all 22 locations
View Trial Details
Completed

Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age

NCT00970307

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +33 more
Locations
  • GSK Investigational Site Bydgoszcz, Poland
  • GSK Investigational Site Dębica, Poland
  • GSK Investigational Site Krakow, Poland
  • GSK Investigational Site Krakow, Poland
View Trial Details
Completed

Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines

NCT00463437

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +38 more
Locations
  • GSK Investigational Site Bad Saulgau, Baden-Wurttemberg, Germany
  • GSK Investigational Site Bönnigheim, Baden-Wurttemberg, Germany
  • GSK Investigational Site Bretten, Baden-Wurttemberg, Germany
  • GSK Investigational Site Ettenheim, Baden-Wurttemberg, Germany
View all 63 locations
View Trial Details
Completed

Treatment With Tamoxifen in Cryptococcal Meningitis

NCT03112031

Conditions
Acquired Immunodeficiency Syndrome, Bacterial Infections and Mycoses, Blood-Borne Infections, +30 more
Locations
  • Cho Ray Hospital Ho Chi Minh City, Vietnam
  • Hospital for Tropical Diseases Ho Chi Minh City, Vietnam
  • Oxford University Clinical Research Unit Ho Chi Minh City, Vietnam
View Trial Details

Related conditions